Clinical Trial Update: A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating ultra-high-dose hypofractionated or single-dose radiotherapy for intermediate-risk prostate cancer; the trial is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING